Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41591-026-04717-8
文献链接: https://www.nature.com/articles/s41591-026-04717-8
其他信息:
出版社: Springer Science and Business Media LLC
作者: MacLean C. Sellars; Jessica A. Frank; Bohoon Shim; Allison Vanasse; Ruolin Liu; Cleo Forman; Chloe R. Tu; Kyohei K. Tabata; Antonia Kowelewski; Su-Chun Cheng; Catherine Song; Kan Xiong; Pia Jain; Andjela Crnjac; Haley E. Sax; Vipheaviny Chea; Wesley Lu; J. Thomas Janes; Micah Rickles-Young; Amit Sud; Savni Sarolkar; Martin Hayes; Oriol Olive; Haley Greenslade; Carrie Cibulskis; Nir Hacohen; Edward F. Fritsch; Shuqiang Li; Kenneth J. Livak; Nabihah Tayob; Elizabeth H. Stover; Carolyn Krasner; Rebecca Porter; Ursula Matulonis; Gad Getz; Giacomo Oliveira; Patrick A. Ott; Jeremy M. Simon; Viktor A. Adalsteinsson; Derin B. Keskin; Panagiotis A. Konstantinopoulos; Catherine J. Wu
全文下载地址: https://www.nature.com/articles/s41591-026-04717-8.pdf
